BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Constellation Brands
STZ
$22.9B
| $24.8M | 0.05% |
130,736
+91,271
| +231% | +$17.2M |
|
427
CALL
Cisco
CSCO
$475B
| $24.6M | 0.04% |
5,138
+1,067
| +26% | +$49.6K |
|
428
Akamai
AKAM
$16.8B
| $24.6M | 0.04% |
284,651
+352
| +0.1% | +$30.8K |
|
|
WMGI
429
DELISTED
Wright Medical Group Inc
WMGI
| $24.6M | 0.04% |
806,659
+754,063
| +1,434% | +$19.7M |
|
430
Corteva
CTVA
$50.9B
| $24.5M | 0.04% |
829,842
-61,674
| -7% | -$1.63M |
|
431
KraneShares CSI China Internet ETF
KWEB
$5.56B
| $24.5M | 0.04% |
502,565
-665,723
| -57% | -$30.4M |
|
432
Ball Corp
BALL
$16.6B
| $24.4M | 0.04% |
377,488
-67,822
| -15% | -$4.6M |
|
433
Fox Class A
FOXA
$26.1B
| $23.8M | 0.04% |
643,121
+487,453
| +313% | +$16.7M |
|
|
LSXMK
434
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $23.8M | 0.04% |
649,759
-752,826
| -54% | -$26.3M |
|
|
ATVI
435
DELISTED
Activision Blizzard
ATVI
| $23.7M | 0.04% |
399,027
-348,384
| -47% | -$19.3M |
|
436
PUT
Deere & Co
DE
$167B
| $23.7M | 0.04% |
1,367
+47
| +4% | +$8.1K |
|
437
PUT
CME Group
CME
$93.2B
| $23.6M | 0.04% |
1,178
+274
| +30% | +$56.2K |
|
438
PUT
Halliburton
HAL
$28.2B
| $23.6M | 0.04% |
9,651
-3,082
| -24% | -$65K |
|
439
CALL
Medtronic
MDT
$116B
| $23.6M | 0.04% |
2,077
-1,099
| -35% | -$121K |
|
|
CY
440
DELISTED
Cypress Semiconductor
CY
| $23.5M | 0.04% |
1,006,223
-2,266,795
| -69% | -$53M |
|
441
Lam Research
LRCX
$390B
| $23.5M | 0.04% |
802,500
-301,500
| -27% | -$8.01M |
|
442
Consolidated Edison
ED
$39.8B
| $23.3M | 0.04% |
257,140
-157,072
| -38% | -$14.1M |
|
|
SCHW
443
PUT
Charles Schwab
SCHW
$186B
| $23.2M | 0.04% |
4,887
+715
| +17% | +$31.5K |
|
444
PNC Financial Services
PNC
$101B
| $23.2M | 0.04% |
145,324
-86,111
| -37% | -$12.9M |
|
|
EXAS
445
DELISTED
Exact Sciences
EXAS
| $23.2M | 0.04% |
250,532
+206,637
| +471% | +$18.2M |
|
446
Morgan Stanley
MS
$338B
| $22.9M | 0.04% |
448,098
-785,394
| -64% | -$37.2M |
|
447
iShares Core US Aggregate Bond ETF
AGG
$137B
| $22.9M | 0.04% |
203,476
+76,388
| +60% | +$8.61M |
|
448
Chubb
CB
$134B
| $22.9M | 0.04% |
146,871
+11,517
| +9% | +$1.76M |
|
449
CF Industries
CF
$17.8B
| $22.7M | 0.04% |
476,437
+170,509
| +56% | +$7.98M |
|
450
Cognizant
CTSH
$26.4B
| $22.7M | 0.04% |
365,492
-44,957
| -11% | -$2.78M |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.